semaglutide and dopamine Exploring the Connection Between Regulation semaglutide effect on dopamine how

Alpanes, M., Alvarez-Blasco, F., Fernandez-Duran, E., Luque-Ramirez, M

Experimental investigations have examined the relationship between NNMT inhibition and regulatory pathways involving nicotinamide turnover, methylation dynamics, transcriptional control mechanisms, and downstream signal transduction processes

DIO mice received treatment with a selective GLP-1 receptor agonist (liraglutide, 0.2 mg/kg, BID) or dual GLP-1/GLP-2 receptor agonist (GUB09145, 0.04 mg/kg, BID) for 4 weeks

By delaying the onset of anaerobic metabolism and reducing intramuscular acidosis, it may help raise a patient's energy envelope, reducing the severity and duration of crashes following minor physical or cognitive exertion